Accessible global health innovations critical to achieving Sustainable Development Goals

By on .

“You can design the most beautiful vaccine or other technology but without proper marketing or dissemination, it will sit on a shelf,” Kaitlin Christenson of PATH said Wednesday. Emphasizing that access and affordability are key to the success of innovations addressing global health concerns, she was speaking at  a Congressional panel focused on the role […]

Development goals should include measures of global health research, report argues

By on .

A new report calls on the United Nations to include global health research and development indicators in the Sustainable Development Goals monitoring framework, set to be adopted later this month. While the SDGs include ambitious targets for reducing child and maternal deaths and eradicating the HIV/AIDS, tuberculosis and malaria epidemics, the report notes, no indicators […]

Tuberculosis R&D “grossly insufficient” according to new report

By on .

The global tuberculosis response and TB research and development remain weak and inadequate despite approval of the first new TB drugs in decades and a new global strategy to reduce TB incidence and mortality, according to Treatment Action Groups’ latest report. With just $255 million spent on TB research and development each year, funding is […]

Study finds diversity in costs, support, and implementation of recommended antiretroviral treatment monitoring

By on .

It’s the best way to ensure antiretroviral treatment is working for those getting it, protecting their immune systems and preventing illness and transmission — and the alternative is more costly. Yet a World Health Organization published study of how frequently antiretroviral treatment programs in seven countries across the Americas check their patients’ viral loads and […]

Ebola vaccine, projections, quarantines, impact — a year after a public health emergency was recognized, we’re reading about results

By on .

This week sees the end of a year since the World Health Organization Emergency Committee on the 2014 Ebola outbreak in west Africa met for the first time, and declared the epidemic to be a “public health emergency of international concern.” As of that week last August, the spread of the largest ever recorded outbreak […]

IAS 2015: HPTN 068 and CAPRISA 007 cash incentive studies show value of school, financial support, but also show more is needed to protect young people from HIV

By on .

VANCOUVER, Canada –  Two clinical trials evaluating the impact of cash incentives on HIV incidence in adolescents  in South Africa found that such incentives had no impact on HIV rates  while one saw a decrease in rates of herpes simplex virus. Nearly 3,000 South African high school students in 14 schools in high HIV incidence […]

IAS 2015: As HPTN 052 ends, Dr. Cohen confirms findings with new insights

By on .

Those whose antiretroviral treatment was delayed never recovered the immune cell counts achieved by those who initiated treatment earlier VANCOUVER, Canada – The first findings from the original “game-changing” HIV treatment study that Science magazine hailed as its “Breakthrough of the Year,” came four years ago, after trial monitors determined they were too good to keep under […]

ShangRing: WHO approval of second nonsurgical circumcision device sets stage for accelerated access to HIV prevention measure

By on .

Latest device approved for use on adolescents, broadening scope of low-cost intervention Call it “VMMC,” for voluntary medical male circumcision, or the current, and more concise “MC” for medical circumcision, by any name, removing men’s foreskins has been proven to lower their risks of acquiring HIV through vaginal sexual intercourse by as much as 60 […]

UNAIDS, Lancet: Take accelerated action on HIV treatment access, research and development, and address epidemic drivers, or risk rebound

By on .

. ” . . . the question is no longer whether the fight against AIDS can be won; the only questions are: will it be won — and when?” An international commission of scientists and others involved in and affected by responses to the global HIV pandemic released findings from a two-year examination of what […]

Diminishing research dollars sparks disease comparisons, competition, while HIV advocates say now is not the time to ease efforts

By on .

As U.S. House and Senate Appropriation Committee members prepare to set funding levels for health and human services that include medical research during the fiscal year ahead, 679 clinicians and researchers as well as leaders of 416 organizations working to prevent, treat and some day end the impact of HIV, have added their names to […]